about
Mechanism-based in vitro screening of potential cancer chemopreventive agentsIdentification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseEpigenetic impact of dietary isothiocyanates in cancer chemoprevention.Impact of soy isoflavones on the epigenome in cancer prevention.Beer constituents as potential cancer chemopreventive agents.Glucosinolates in Brassica vegetables: the influence of the food supply chain on intake, bioavailability and human health.Cancer chemoprevention by targeting the epigenome.Role of lncRNAs in prostate cancer development and progression.Pan-cancer patterns of DNA methylation.Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer.Xanthohumol-induced transient superoxide anion radical formation triggers cancer cells into apoptosis via a mitochondria-mediated mechanism.In vitro chemopreventive potential of fucophlorethols from the brown alga Fucus vesiculosus L. by anti-oxidant activity and inhibition of selected cytochrome P450 enzymes.Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities.Identification of 3-hydroxy-beta-damascone and related carotenoid-derived aroma compounds as novel potent inducers of Nrf2-mediated phase 2 response with concomitant anti-inflammatory activity.Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro.Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention.Time-dependent modulation of thioredoxin reductase activity might contribute to sulforaphane-mediated inhibition of NF-kappaB binding to DNA.Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor- and mitochondrial pathway.Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site.Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells.Xanthohumol metabolites in faeces of rats.Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.Monodictyochromes A and B, dimeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis.Xanthohumol does not affect the composition of rat intestinal microbiota.A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats.Fractionation of polyphenol-enriched apple juice extracts to identify constituents with cancer chemopreventive potential.Xanthohumol, a new all-rounder?Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.Intratumor heterogeneity in epigenetic patterns.[Isoflavone-containing dietary supplements].Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.Dose-dependent effects of isoflavone exposure during early lifetime on the rat mammary gland: Studies on estrogen sensitivity, isoflavone metabolism, and DNA methylation.Impact of dietary gut microbial metabolites on the epigenome.Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity.A click chemistry approach identifies target proteins of xanthohumol.Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.Development of novel cancer chemopreventive agents in Europe – Neglected Cinderella or rising phoenix?
P50
Q28195340-5219DC39-E318-4B8C-B820-1AFFCF3DECD1Q33895047-5B702244-432B-4705-ADC9-DAA1E291460DQ34343612-32E59C73-6547-4EEC-BEB7-DD96F803002EQ34411665-70DD66EA-CDFA-4073-850F-CBA3B64A853CQ34426166-09AD9210-B8C0-4E21-9936-1B3851DAB45AQ37335361-D648395D-035F-425D-B22F-05CB60F17316Q37821016-6C8C6D84-E3E4-4298-8BCC-D186ED11B60AQ38242921-0928CE10-DACD-442F-906C-B378550E7071Q38282894-D919482F-B382-4196-B2F6-5B2A08F0877EQ38875015-B3B58CFD-4D2B-4F84-BF21-391D4A3352D4Q39723404-06594F8F-ED22-4E5A-B1B1-3C33652D743EQ39768305-BE7B3F86-523E-48BC-B722-0420979FB933Q39782976-CB6BA7D6-1432-4BEF-92EA-D02404EDA86EQ39799717-3F0B6A05-5535-462C-86C8-FE12A5F42EB6Q40164660-AFBF569E-9DBF-4A7B-9CA9-021C0988EF03Q40302650-28F436A1-7EE9-42DE-8157-90A01B314E2AQ40339905-DE887829-4BDD-431E-A64A-81731EBCD812Q40402125-0AA77C69-BDD8-4C6A-8925-9F308C9B3547Q40798546-5BA756D5-210C-425A-89DC-E5BD568F1025Q41093581-F410C365-AE59-4E9B-B819-BEB54AF68E30Q41521633-84769621-4BDE-4279-AC49-4F20ED2CB377Q44057473-8353AD7B-E871-4623-9FCE-9B69F2B76460Q44788085-EC526FE5-E48B-430E-A3D0-26FEAD9CFABBQ45017329-54264B9B-BA54-4E4C-B9AC-4AB65CEA1F11Q46306130-0B44F713-D3BB-4746-A3B8-DAECB9D3FE52Q46643560-66B84630-0E58-4939-9A63-DD2311554A9BQ46643569-00CBE65B-ABD4-4577-8251-0319BBC3E2E3Q46655915-6EBA1208-4703-42B2-9F39-05A67573244CQ46688677-919A88F9-1C98-4AA1-8A8A-EEC6C0FC27EDQ47111892-E43D1CA9-C6F4-4C88-88A9-B475CC7DAF2EQ48293367-DFDEA94C-4387-4A9D-AFC1-B88DA0B3098FQ49792302-D2786113-D1F0-48D6-BA24-3951F29FCCBCQ50457120-3370E779-30C0-4DE6-A72C-2B26B4C70670Q51064042-FA179E07-ACB4-40F9-B477-AF4D40CE8E54Q51075969-2429BDAD-5C27-4242-8B55-BF2F6378EE0BQ52312163-9BABB9C0-9123-4B65-83A2-56B6070CA107Q52632561-D0B82A47-F74D-4B7A-A035-34084FA3E97BQ52889907-D40A9FAB-E9C2-4CC8-AC05-B054FBF8D451Q53148930-699D7CE5-62F4-43EA-9F4F-3F3E6A05DED4Q57424333-CC84A396-84EC-4F38-9DA5-79AC592B69F7
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Clarissa Gerhäuser
@ast
Clarissa Gerhäuser
@en
Clarissa Gerhäuser
@es
Clarissa Gerhäuser
@nl
Clarissa Gerhäuser
@sl
type
label
Clarissa Gerhäuser
@ast
Clarissa Gerhäuser
@en
Clarissa Gerhäuser
@es
Clarissa Gerhäuser
@nl
Clarissa Gerhäuser
@sl
prefLabel
Clarissa Gerhäuser
@ast
Clarissa Gerhäuser
@en
Clarissa Gerhäuser
@es
Clarissa Gerhäuser
@nl
Clarissa Gerhäuser
@sl
P214
P227
P106
P1153
6603918298
P21
P213
0000 0003 5769 0519
P214
P227
P31
P496
0000-0002-5792-3901
P569
1964-01-01T00:00:00Z
P734
P735
P7859
viaf-200223202